Novartis Sues To Block Generic Reclast, Zometa Drugs
Novartis Pharmaceuticals Corp. filed a lawsuit Wednesday in New Jersey federal court seeking to bar more than a dozen drugmakers from making generic versions of its osteoporosis drug Reclast and oncology...To view the full article, register now.
Already a subscriber? Click here to view full article